K72.1 Chronic hepatic failure

Name of the Condition

• Chronic Hepatic Failure (ICD-10 Code: K72.1)

Summary

Chronic hepatic failure is a progressive and irreversible decline in liver function that develops over months or years. The liver’s ability to perform essential metabolic, detoxification, and synthetic functions is severely compromised, leading to systemic complications. This condition is distinguished by its chronic course and is identified through clinical evaluation, laboratory tests, and exclusion of acute liver failure.

Causes

Chronic hepatic failure typically results from long-standing liver injury, such as cirrhosis due to viral hepatitis (e.g., hepatitis B or C), alcohol-related liver disease, nonalcoholic fatty liver disease, or autoimmune hepatitis. Other causes may include metabolic disorders (e.g., hemochromatosis, Wilson disease) or chronic drug-induced liver injury. In some cases, the underlying cause remains unidentified despite thorough investigation.

Risk Factors

• Chronic liver disease (e.g., cirrhosis, hepatitis).
• Viral infections (hepatitis B or C).
• Alcohol abuse or toxic substance exposure.
• Autoimmune conditions affecting the liver.
• Metabolic disorders (e.g., Wilson disease, hemochromatosis).
• Prolonged use of hepatotoxic medications or herbal supplements.

Symptoms

• Jaundice (yellowing of skin and eyes).
• Fatigue, weakness, or malaise.
• Abdominal swelling (ascites) or pain.
• Nausea, vomiting, or loss of appetite.
• Easy bruising or bleeding (coagulopathy).
• Confusion or altered mental status (hepatic encephalopathy).
• Pruritus (itching).
• Muscle wasting or weight loss.

Diagnosis

Diagnosis involves a combination of clinical assessment, laboratory tests (e.g., liver function tests, coagulation studies, ammonia levels), imaging (e.g., ultrasound, MRI), and liver biopsy (if needed). Exclusion of acute liver failure and other specific liver disorders is critical. Clinical criteria, such as the Model for End-Stage Liver Disease (MELD) score, may be used to assess severity.

Treatment Options

Treatment focuses on managing complications and slowing disease progression. Interventions may include dietary modifications (e.g., protein restriction for encephalopathy), medications (e.g., lactulose, rifaximin), diuretics for ascites, and addressing underlying causes (e.g., antiviral therapy for hepatitis). In advanced cases, liver transplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the severity of liver dysfunction, underlying cause, and response to treatment. Chronic hepatic failure often requires long-term monitoring for complications (e.g., infections, renal failure). Regular follow-up with liver function tests, imaging, and clinical evaluations is essential to adjust management and assess transplant eligibility.

Complications

• Hepatic encephalopathy (altered mental status).
• Ascites (abdominal fluid accumulation).
• Spontaneous bacterial peritonitis.
• Variceal bleeding (from esophageal or gastric veins).
• Hepatorenal syndrome (kidney failure).
• Coagulopathy (bleeding disorders).
• Malnutrition or muscle wasting.

Lifestyle & Prevention

• Avoid alcohol and hepatotoxic substances.
• Maintain a balanced diet with adequate protein and low sodium.
• Manage underlying conditions (e.g., viral hepatitis, diabetes).
• Vaccinate against hepatitis A and B.
• Avoid over-the-counter medications or supplements without medical guidance.
• Regular exercise and weight management (for nonalcoholic fatty liver disease).

When to Seek Professional Help

Seek immediate medical attention for symptoms like severe jaundice, confusion, abdominal pain, or uncontrolled bleeding. Prompt evaluation is critical for managing complications or considering transplant referral.

Tips for Medical Coders

Document the underlying cause (e.g., cirrhosis, hepatitis) and clinical findings (e.g., encephalopathy, ascites) to support code assignment. Ensure the chronic nature of the condition is clearly documented, as this distinguishes it from acute hepatic failure. Verify that no more specific code (e.g., for coma or subacute presentation) applies before using K72.1.